InvestorsHub Logo
Followers 5
Posts 859
Boards Moderated 0
Alias Born 07/27/2010

Re: austrochris post# 874

Sunday, 06/07/2015 5:53:50 PM

Sunday, June 07, 2015 5:53:50 PM

Post# of 3723
Known fact is, Palatin is looking for a U.S. partner to help continue the development and commercialization of BMT (Bremelanotide). If a name like Pfizer gets in the mix, I'd be very happy.

All of the previous meetings, PTN management has stated they were looking to have their U.S. partnership locked up this year. Gideon Richer, signed as their European partner not too long ago and even paid out a milestone payment of ~3 million USD.

So the potential is there. I like the linkage to Pfizer and Palatin. Hopefully, with the FDA approving a female sexual drug, this can help accelerate PTN finding and inking a U.S. partner.


However, its not JOHN K.A. PRENDERGAST that is linked to Pfizer, its Angela Rossetti:

ANGELA ROSSETTI
Director

Ms. Rossetti has been a director since June 2013. From 2009 through January 2012, she was a vice president at Pfizer Inc., where she led a global commercial medicine team for a smoking cessation franchise. She was an assistant vice president at Wyeth, managing a global hemophilia franchise from 2007 until 2009, when Wyeth was acquired by Pfizer. From 2005 to 2006 she was president of Ogilvy Healthworld, an advertising business in the pharmaceutical and biotechnology sectors. Previously she worked in a variety of increasingly responsible positions in communications, marketing and venture capital/investment banking.

insert-text-here
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PTN News